ARCHIVES

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

This article is from The Cancer Letter archive.

Vol. 32 No. 16 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Diane Fink Accepts VP Job With ACS

April 3, 1981

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995

CCI Will Tackle Reimbursement Issue

May 16, 1980